21. Number of Prescription Drugs and Overall Survival in Metastatic Castrate Resistant Prostate Cancer

Introduction: Assessment of comorbidities is essential to clinical research and predicts adverse events and death. Prescription medications could be a tool for predicting risk independent of the Charlson Comorbidity Index (CCI). Additionally, clinicians have access to prescription medication lists, facilitating assessment of comorbidities. Methods: Retrospective study conducted of US Veterans treated for metastatic castrate resistant […]